01 3Gowling WLG (Canada) LLP
01 12550361
02 12613015
03 12738573
01 3Vemurafenib
01 3Tablet
01 12024-12-17
02 12026-06-21
03 12030-03-31
Patent Expiration Date : 2030-03-31
Date Granted : 2013-02-19
Brand Name : ZELBORAF
Patent Number : 2738573
Filing Date : 2010-03-31
Strength per Unit : 240 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2030-03-31
Date Granted : 2013-02-19
Patent Expiration Date : 2026-06-21
Date Granted : 2012-04-03
Brand Name : ZELBORAF
Patent Number : 2613015
Filing Date : 2006-06-21
Strength per Unit : 240 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-06-21
Date Granted : 2012-04-03
Patent Expiration Date : 2024-12-17
Date Granted : 2014-04-29
Brand Name : ZELBORAF
Patent Number : 2550361
Filing Date : 2004-12-17
Strength per Unit : 240 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-12-17
Date Granted : 2014-04-29
